Amr Elshahat

Amr Elshahat, MBBCh, an Associate Research Scientist, is deeply interested in neurology and neurosciences, with a particular commitment and passion to the molecular mechanisms of neurodegenerative diseases. He completed medical school at Benha University and worked as a PCP in the underserved areas of Egypt.

He primarily joined the Yale Stroke Department as a Visiting Research Scientist in 2023. He explored intracerebral hemorrhage and the predictive factors for the development of poststroke epilepsy. He worked with multiple Yale educators and attending physicians in the areas of stroke, movement disorders, and epilepsy. He developed a particular interest in the pathophysiology and molecular basis of Parkinson’s disease. In October 2024, he transferred to the PET NeuroImaging Program in the Radiology and Biomedical department to study PET biomarkers in Parkinson’s Disease using radiotracers that quantify synaptic density and dopamine availability. In May 2025, he began serving as a co-investigator in “The Ketamine in the Treatment of Depression in PD: A multisite double-blinded RCT” and “The Psilocybin in the Treatment of Depression in PD: A multisite double-blinded RCT.” In October 2025, he began a new academic position as an Associate Research Scientist in the Department of Radiology at Yale School of Medicine.